Clinical trials
Trigger Finger Disorder trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 9 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 5 |
| Withdrawn | 3 |
| Recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 3 |
| University of Texas at Austin | 3 |
| Cedars-Sinai Medical Center | 2 |
| Emory University | 2 |
| Massachusetts General Hospital | 2 |
| NYU Langone Health | 2 |
| University of Arizona | 2 |
| University of Utah | 2 |
| Alexander Payatakes, M.D. | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Trigger Finger Disorder | 35 |
| Carpal Tunnel Syndrome | 9 |
| Dupuytren Contracture | 5 |
| Ganglion Cysts | 5 |
| De Quervain Disease | 4 |
| Pain | 3 |
| Tendon Entrapment | 3 |
| Osteoarthritis | 2 |
| Tendinopathy | 2 |
| Tennis Elbow | 2 |
Trials
Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.